Clinical trial highlights: Dopamine cell-replacement therapies.

Parkinson's disease is a common neurodegenerative disorder, which is characterised by motor features, many of which relate to the loss of the dopaminergic nigrostriatal pathway. The use of grafted cells to replace the lost dopaminergic neurons as a t…

Preview only. Read the full abstract at the source